Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a clinical trial registry record with no reported results; the study is actively recruiting and designed to evaluate trontinemab in preclinical Alzheimer's disease, but outcome data are not yet available.
This is a Phase 1 clinical trial registry record with no results posted; it describes planned safety and tolerability assessment in a small early-stage cohort.
A terminated Phase 2/3 RCT with no results posted; the registry record documents planned design and enrollment only, without outcome data or efficacy findings.
This is a pilot study registration with no results posted; it is designed to test a novel hypothesis about ECT in Alzheimer's disease, too early to provide clinical evidence of efficacy.
This is a recruiting observational cohort study with no results posted; it is an early-phase data collection effort designed to characterize tau PET patterns and their relationship to clinical phenotypes in cognitive impairment.
In vitro mechanistic study using cell co-culture models to explore MALT1 inhibition as a potential AD target; no animal or clinical validation provided.
Cross-species translational study with human observational data showing a novel non-linear association, but limited by lack of prospective design, mechanistic uncertainty, and authors' own call for validation in independent cohorts.